Autres langues DHG Pharmaceutical

Actions

DHG

VN000000DHG0

Produits pharmaceutiques

Cours en clôture Ho Chi Minh S.E. 28/09/2026			Varia. 5j.	Varia. 1 janv.
90 000,00 ^VND	-0,11%		-0,55%	-12,02%

21/08	DHG Pharma annonce le dividende final pour 2025, payable le 30 septembre 2026	CI
20/07	DHG Pharmaceutical Joint Stock Company publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

21/08	DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026
20/07	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
14/07	Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company
25/05	DHG Pharmaceutical Joint Stock Company Receives the Confirmation Certificate of Registration Changes
29/04	DHG Pharmaceutical Joint Stock Company Announces Adjustment of Position of Osamu Fujimori as Deputy General Director in Charge of Finance and Supply Chain, Effective May 1, 2026
23/04	DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2026
23/04	DHG Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 21, 2026
23/04	DHG Pharmaceutical Joint Stock Company Approves Dividend for the Fiscal Year Ended December 31, 2025, Payable on 28 May 2026 and in September 2026
23/04	DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Fiscal Year 2026
20/04	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026
26/03	DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2026
20/01	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
06/01	DHG Pharmaceutical Joint Stock Company Announces Change in Certificate of Business Registration
20/10/25	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
29/08/25	DHG Pharmaceutical Joint Stock Company Appoints Ta Thanh Hung as Director, Effective September 1, 2025
19/07/25	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
18/04/25	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025
21/01/25	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
13/12/24	DHG Pharmaceutical Joint Stock Company Approves 2024 Cash Dividend, Payable on February 14, 2025
19/10/24	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
29/07/24	DHG Pharmaceutical Joint Stock Company Announces Second Cash Dividend of 2023, Payable on August 21, 2024
19/07/24	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
09/07/24	DHG Pharmaceutical Joint Stock Company Announces Resignation of Vu Thi Huong Lan as Hr Director, Effective from July 15, 2024
09/07/24	DHG Pharmaceutical Joint Stock Company Announces Resignation of Nhung Thi Hong Le as Finance Director, Effective from July 15, 2024
01/07/24	DHG Pharmaceutical Joint Stock Company Announces Resignation of Doan Dinh Duy Khuong from Position of BOD Member and Chief Operating Officer